Health Care & Life Sciences » Pharmaceuticals | Sino Biopharmaceutical Ltd.

Sino Biopharmaceutical Ltd. | Ownership

Companies that own Sino Biopharmaceutical Ltd.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
The Vanguard Group, Inc.
215,788,978
1.71%
-138,001
0.01%
07/31/2018
Wellington Management Co. LLP
172,486,819
1.37%
17,107,491
0.04%
07/31/2018
BlackRock Fund Advisors
137,593,500
1.09%
278,000
0.01%
09/06/2018
JF Asset Management Ltd.
124,716,000
0.99%
0
0.68%
06/27/2017
Harding Loevner LP
112,828,141
0.89%
704,855
0.35%
06/30/2018
First State Investments (Hong Kong) Ltd.
100,671,000
0.8%
-31,758,000
1.18%
01/31/2018
Norges Bank Investment Management
70,797,890
0.56%
-24,915,597
0.01%
12/31/2017
UBS Asset Management (Hong Kong) Ltd.
57,910,500
0.46%
-1,876,500
1.68%
01/31/2018
BAMCO, Inc.
56,390,961
0.45%
-12,470,169
0.25%
06/30/2018
Dimensional Fund Advisors LP
51,965,052
0.41%
-461,945
0.02%
04/30/2018

About Sino Biopharmaceutical

View Profile
Address
Unit 09, 41st Floor, Office Tower
Hong Kong
Hong Kong
Employees -
Website http://www.sinobiopharm.com
Updated 07/08/2019
Sino Biopharmaceutical Ltd. is an investment holding company, which engages in the manufacture and sale of pharmaceutical products. It operates through the following business segments: Modernised Chinese Medicines and Chemical Medicines, Investment, and Others. The Modernised Chinese Medicines and Chemical Medicines segment comprises the manufacturing, selling, and distribution of modernized Chinese medicine products and western medicine products.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.